Jason Flowerday

Biography

Jason Flowerday is a highly respected general manager and leader with two decades of executive life sciences management and startup experience. He consistently develops his entrepreneurial drive and is a passionate leader and champion for change. Jason is currently the Chief Executive Officer for 3D Signatures Inc. (TSX-V: DXD), a novel personalized medicine company with a proprietary software platform based on the three-dimensional analysis of a patient’s individual chromosomal arrangement – or signature. For over a decade, Jason was groomed at two of the world’s largest pharmaceutical companies, Germany’s Bayer AG and US-based Johnson and Johnson before expanding his successful career into leading specialty pharmaceutical, biotech and device companies in their pursuit of growth and capital. Jason is also a Director of Aequus Pharmaceuticals (TSX-V: AQS), which allows him to leverage his network and apply his specialty pharma experience.

Research Interest

 Pharmaceuticals